Anemia Clinical Trial
Official title:
Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Correction of Anemia in Subjects With Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CORRECTION)
| Verified date | June 2022 |
| Source | Akebia Therapeutics |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction of anemia and maintenance of hemoglobin (Hb) in participants with Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)
| Status | Completed |
| Enrollment | 1751 |
| Est. completion date | July 31, 2020 |
| Est. primary completion date | June 4, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - =18 years of age - Diagnosis of chronic kidney disease (CKD) with an estimated glomerular filtration rate =60 milliliters per minute per 1.73 square meter (mL/min/1.73 m^2) at Screening and not expected to start dialysis within 6 months of Screening - Mean Screening hemoglobin <10.0 grams per deciliter (g/dL) - Serum ferritin =100 nanograms per milliliter (ng/mL) and transferrin saturation (TSAT) =20% during Screening Exclusion Criteria: - Anemia due to a cause other than CKD or participants with active bleeding or recent blood loss - Red blood cell transfusion within 8 weeks prior to randomization. - Any erythropoietic stimulating agent within 8 weeks prior to randomization - Uncontrolled hypertension - Severe heart failure at Screening (New York Heart Association Class IV) - Acute coronary syndrome (hospitalization for unstable angina or myocardial infarction), surgical or percutaneous intervention for coronary, cerebrovascular, or peripheral artery disease (aortic or lower extremity), surgical or percutaneous valvular replacement or repair, sustained ventricular tachycardia, hospitalization for heart failure, or stroke within 12 weeks prior to or during Screening - Hypersensitivity to Darbepoetin or Vadadustat or to any of their excipients |
| Country | Name | City | State |
|---|---|---|---|
| Argentina | Research Site | Bahia Blanca | Buenos Aires |
| Argentina | Research Site | Ciudad Autonoma Buenos Aires | |
| Argentina | Research Site | Ciudad Autonoma Buenos Aires | |
| Argentina | Research Site | Cordoba | |
| Argentina | Research Site | Cordoba | |
| Argentina | Research Site | Cordoba | |
| Argentina | Research Site | Cordoba | |
| Argentina | Research Site | Corrientes | |
| Argentina | Research Site | Godoy Cruz | Mendoza |
| Argentina | Research Site | Junin | Buenos Aires |
| Argentina | Research Site | Junin | Buenos Aires |
| Argentina | Research Site | Mar del Plata | Buenos Aires |
| Argentina | Research Site | Mar del Plata | Buenos Aires |
| Argentina | Research Site | Pergamino | Buenos Aires |
| Argentina | Research Site | Ramos Mejia | Buenos Aires |
| Argentina | Research Site | Rosario | Santa Fe |
| Argentina | Research Site | Salta | |
| Argentina | Research Site | San Luis | |
| Argentina | Research Site | San Miguel | Buenos Aires |
| Argentina | Research Site | San Miguel de Tucuman | Tucuman |
| Argentina | Research Site | San Miguel de Tucuman | Tucuman |
| Argentina | Research Site | San Miguel de Tucuman | Tucuman |
| Argentina | Research Site | San Miguel de Tucuman | Tucuman |
| Argentina | Research Site | San Nicolas | Buenos Aires |
| Argentina | Research Site | Sarandi | Buenos Aires |
| Argentina | Research Site | Temperley | Buenos Aires |
| Australia | Research Site | Adelaide | South Australia |
| Australia | Research Site | Bedford Park | South Australia |
| Australia | Research Site | Box Hill | Victoria |
| Australia | Research Site | Cairns | Queensland |
| Australia | Research Site | Camperdown | New South Wales |
| Australia | Research Site | Gold Coast | Queensland |
| Australia | Research Site | Herston | Queensland |
| Australia | Research Site | Liverpool | New South Wales |
| Australia | Research Site | Nedlands | Western Australia |
| Australia | Research Site | Perth | Western Australia |
| Brazil | Research Site | Belo Horizonte | Minas Gerais |
| Brazil | Research Site | Botucatu | Sao Paulo |
| Brazil | Research Site | Campinas | Sao Paulo |
| Brazil | Research Site | Canoas | Rio Grande Do Sul |
| Brazil | Research Site | Caxias do Sul | Rio Grande Do Sul |
| Brazil | Research Site | Criciúma | Santa Catarina |
| Brazil | Research Site | Curitiba | Paraná |
| Brazil | Research Site #1 | Curitiba | Paraná |
| Brazil | Research Site #2 | Curitiba | Paraná |
| Brazil | Research Site | Feira de Santana | Bahia |
| Brazil | Research Site | Fortaleza | Ceará |
| Brazil | Research Site | Fortaleza | Ceará |
| Brazil | Research Site | Itabuna | Bahia |
| Brazil | Research Site | Joinville | Santa Catarina |
| Brazil | Research Site | Juiz de Fora | Minas Gerais |
| Brazil | Research Site | Maringá | Paraná |
| Brazil | Research Site | Passo Fundo | Rio Grande Do Sul |
| Brazil | Research Site | Porto Alegre | Rio Grande Do Sul |
| Brazil | Research Site | Porto Alegre | Rio Grande Do Sul |
| Brazil | Research Site | Porto Alegre | Rio Grande Do Sul |
| Brazil | Research Site | Porto Alegre | Rio Grande Do Sul |
| Brazil | Research Site | Rio de Janeiro | Rio Do Janeiro |
| Brazil | Research Site | Santo André | Sao Paulo |
| Brazil | Research Site | Santo André | Sao Paulo |
| Brazil | Research Site | São Bernardo do Campo | Sao Paulo |
| Brazil | Research Site | São Paulo | Sao Paulo |
| Brazil | Research Site | São Paulo | Sao Paulo |
| Brazil | Research Site | São Paulo | Sao Paulo |
| Brazil | Research Site | Vitória | Espírito Santo |
| Bulgaria | Research Site | Dobrich | |
| Bulgaria | Research Site | Lom | |
| Bulgaria | Research Site | Silistra | |
| Bulgaria | Research Site | Sliven | |
| Bulgaria | Research Site | Smolyan | |
| Bulgaria | Research Site | Sofia | |
| Bulgaria | Research Site | Sofia | |
| Bulgaria | Research Site | Sofia | |
| Bulgaria | Research Site | Sofia | |
| Bulgaria | Research Site #1 | Sofia | |
| Bulgaria | Research Site #2 | Sofia | |
| Bulgaria | Research Site | Stara Zagora | |
| Bulgaria | Research Site | Stara Zagora | |
| Bulgaria | Research Site | Varna | |
| Bulgaria | Research Site | Varna | |
| Bulgaria | Research Site #1 | Veliko Tarnovo | |
| Bulgaria | Research Site #2 | Veliko Tarnovo | |
| Bulgaria | Research Site | Vidin | |
| France | Research Site | Pontoise | Val d'Oise |
| Hungary | Research Site #1 | Baja | |
| Hungary | Research Site #2 | Baja | |
| Hungary | Research Site | Balatonfured | |
| Hungary | Research Site | Budapest | |
| Hungary | Research Site | Budapest | |
| Hungary | Research Site | Debrecen | |
| Hungary | Research Site | Hodmezovasarhely | |
| Hungary | Research Site | Kalocsa | |
| Hungary | Research Site | Kaposvar | |
| Hungary | Research Site | Kecskemet | |
| Hungary | Research Site | Kistarcsa | |
| Hungary | Research Site | Nyiregyhaza | |
| Hungary | Research Site | Pecs | |
| Hungary | Research Site | Szeged | |
| Hungary | Research Site | Szigetvar | |
| Israel | Research Site | Ashkelon | |
| Israel | Research Site | Haifa | |
| Israel | Research Site | Nahariya | |
| Israel | Research Site | Ramat Gan | |
| Israel | Research Site | Rishon Lezion | |
| Italy | Research Site | Bari | |
| Italy | Research Site | Bergamo | |
| Italy | Research Site | Cremona | |
| Italy | Research Site | Genova | |
| Italy | Research Site | Lecco | |
| Italy | Research Site | Milano | |
| Italy | Research Site | Napoli | |
| Italy | Research Site | Napoli | |
| Italy | Research Site | Parma | |
| Italy | Research Site | Pavia | |
| Italy | Research Site | Piedimonte Matese | Caserta |
| Italy | Research Site | Roma | |
| Italy | Research Site | San Giovanni Rotondo | Foggia |
| Italy | Research Site | Siena | |
| Korea, Republic of | Research Site | Bucheon-si | Gyeonggi-do |
| Korea, Republic of | Research Site | Busan | |
| Korea, Republic of | Research Site | Busan | |
| Korea, Republic of | Research Site | Daegu | |
| Korea, Republic of | Research Site | Guri-si | Gyeonggi-do |
| Korea, Republic of | Research Site | Seoul | |
| Korea, Republic of | Research Site | Seoul | |
| Malaysia | Research Site | Kota Bahru | Kelantan |
| Malaysia | Research Site | Kuantan | Pahang |
| Mexico | Research Site | Acapulco de Juarez | Guerrero |
| Mexico | Research Site | Chihuahua | |
| Mexico | Research Site | Chihuahua | |
| Mexico | Research Site | Culiacan | Sinaloa |
| Mexico | Research Site | Culiacan | Sinaloa |
| Mexico | Research Site | Culiacán | Sinaloa |
| Mexico | Research Site | Durango | |
| Mexico | Research Site | Guadalajara | Jalisco |
| Mexico | Research Site | Mazatlan | Sinaloa |
| Mexico | Research Site | Mexico | Distrito Federal |
| Mexico | Research Site | Mexico | Distrito Federal |
| Mexico | Research Site | Monterrey | Nuevo León |
| Mexico | Research Site | Morelia | Michoacán |
| Mexico | Research Site | Pachuca | Hidalgo |
| Mexico | Research Site | Pachuca | Hidalgo |
| Mexico | Research Site | San Juan del Rio | Queretaro |
| Mexico | Research Site | Veracruz | |
| Mexico | Research Site | Zapopan | Jalisco |
| Mexico | Research Site | Zapopan | Jalisco |
| New Zealand | Research Site | Hamilton | |
| New Zealand | Research Site | New Plymouth | |
| Poland | Research Site | Lodz | |
| Poland | Research Site | Lodz | |
| Poland | Research Site | Nowa Sol | |
| Poland | Research Site | Warszawa | |
| Poland | Research Site | Wroclaw | |
| Puerto Rico | Research Site | Caguas | |
| Russian Federation | Research Site | Kazan | |
| Russian Federation | Research Site | Kemerovo | |
| Russian Federation | Research Site | Krasnoyarsk | |
| Russian Federation | Research Site | Moscow | |
| Russian Federation | Research Site | Nizhniy Novgorod | |
| Russian Federation | Research Site | Novosibirsk | |
| Russian Federation | Research Site | Novosibirsk | |
| Russian Federation | Research Site | Novosibirsk | |
| Russian Federation | Research Site | Petrozavodsk | |
| Russian Federation | Research Site | Pushkin | |
| Russian Federation | Research Site | Saint-Petersburg | |
| Russian Federation | Research Site | Saint-Petersburg | |
| Russian Federation | Research Site | Saint-Petersburg | |
| Russian Federation | Research Site | Saint-Petersburg | |
| Russian Federation | Research Site | Tomsk | |
| Russian Federation | Research Site | Tosno | |
| Russian Federation | Research Site | Yaroslavl | |
| South Africa | Research Site | Bloemfontein | Free State |
| South Africa | Research Site | Brandfort | Free State |
| South Africa | Research Site | Cape Town | Western Cape |
| South Africa | Research Site | Durban | KwaZulu-Natal |
| South Africa | Research Site | Durban | KwaZulu-Natal |
| South Africa | Research Site | Durban | KwaZulu-Natal |
| South Africa | Research Site #1 | Durban | KwaZulu-Natal |
| South Africa | Research Site #2 | Durban | KwaZulu-Natal |
| South Africa | Research Site | George | Western Cape |
| South Africa | Research Site | Port Elizabeth | Eastern Cape |
| South Africa | Research Site | Pretoria | Gauteng |
| South Africa | Research Site #1 | Pretoria | Gauteng |
| South Africa | Research Site #2 | Pretoria | Gauteng |
| South Africa | Research Site | Somerset West | Western Cape |
| South Africa | Research Site | Tongaat | KwaZulu-Natal |
| South Africa | Research Site | Vereeniging | Gauteng |
| South Africa | Research Site | Worcester | Western Cape |
| Spain | Research Site | Almeria | |
| Spain | Research Site | Almeria | |
| Spain | Research Site | Badajoz | |
| Spain | Research Site | Barcelona | |
| Spain | Research Site | Elche | Alicante |
| Spain | Research Site | L'Hospitalet de Llobregat | Barcelona |
| Spain | Research Site | Madrid | |
| Spain | Research Site | Malaga | Málaga |
| Spain | Research Site | Palma de Mallorca | Baleares |
| Spain | Research Site | Sevilla | |
| Spain | Research Site | Sevilla | |
| Spain | Research Site | Torrevieja | Alicante |
| Spain | Research Site | Valencia | |
| Spain | Research Site | Valencia | |
| Ukraine | Research Site | Dnipro | |
| Ukraine | Research Site | Ivano-Frankivsk | |
| Ukraine | Research Site | Ivano-Frankivsk | |
| Ukraine | Research Site | Kharkiv | |
| Ukraine | Research Site | Kharkiv | |
| Ukraine | Research Site | Kharkiv | |
| Ukraine | Research Site | Kharkiv | |
| Ukraine | Research Site | Kropyvnytskyi | |
| Ukraine | Research Site | Kyiv | |
| Ukraine | Research Site | Kyiv | |
| Ukraine | Research Site | Lviv | |
| Ukraine | Research Site | Lviv | |
| Ukraine | Research Site | Mykolaiv | |
| Ukraine | Research Site | Odesa | |
| Ukraine | Research Site | Vinnytsia | |
| Ukraine | Research Site | Vinnytsia | |
| Ukraine | Research Site | Vinnytsia | |
| Ukraine | Research Site | Zaporizhzhia | |
| Ukraine | Research Site | Zaporizhzhia | |
| Ukraine | Research Site | Zhytomyr | |
| United Kingdom | Research Site | Aberdeen | Grampian Region |
| United Kingdom | Research Site | Doncaster | South Yorkshire |
| United Kingdom | Research Site | Leicester | Leicestershire |
| United Kingdom | Research Site | London | Greater London |
| United Kingdom | Research Site | London | Greater London |
| United Kingdom | Research Site | Salford | Greater Manchester |
| United Kingdom | Research Site | Sheffield | South Yorkshire |
| United Kingdom | Research Site | Stevenage | Hertfordshire |
| United Kingdom | Research Site | Swansea | |
| United States | Research Site | Akron | Ohio |
| United States | Research Site | Albuquerque | New Mexico |
| United States | Research Site | Albuquerque | New Mexico |
| United States | Research Site | Albuquerque | New Mexico |
| United States | Research Site | Alexandria | Virginia |
| United States | Research Site | Anaheim | California |
| United States | Research Site | Anderson | South Carolina |
| United States | Research Site | Anderson | Indiana |
| United States | Research Site | Arlington | Texas |
| United States | Research Site | Arlington | Virginia |
| United States | Research Site | Arvada | Colorado |
| United States | Research Site | Asheville | North Carolina |
| United States | Research Site | Atlanta | Georgia |
| United States | Research Site | Atlanta | Georgia |
| United States | Research Site | Atlanta | Georgia |
| United States | Research Site #1 | Augusta | Georgia |
| United States | Research Site #2 | Augusta | Georgia |
| United States | Research Site | Bakersfield | California |
| United States | Research Site | Baltimore | Maryland |
| United States | Research Site | Berlin | New Jersey |
| United States | Research Site | Bradenton | Florida |
| United States | Research Site | Brandon | Florida |
| United States | Research Site | Bronx | New York |
| United States | Research Site | Butte | Montana |
| United States | Research Site | Chattanooga | Tennessee |
| United States | Research Site | Chicago | Illinois |
| United States | Research Site #1 | Chula Vista | California |
| United States | Research Site #2 | Chula Vista | California |
| United States | Research Site | Cincinnati | Ohio |
| United States | Research Site | Clinton | Utah |
| United States | Research Site | Columbia | Missouri |
| United States | Research Site | Columbus | Georgia |
| United States | Research Site #1 | Columbus | Georgia |
| United States | Research Site #2 | Columbus | Georgia |
| United States | Research Site | Cooper City | Florida |
| United States | Research Site #1 | Coral Gables | Florida |
| United States | Research Site #2 | Coral Gables | Florida |
| United States | Research Site | Coral Springs | Florida |
| United States | Research Site | Coral Springs | Florida |
| United States | Research Site | Dallas | Texas |
| United States | Research Site | Dallas | Texas |
| United States | Research Site | Danville | Virginia |
| United States | Research Site | Dayton | Ohio |
| United States | Research Site | Denver | Colorado |
| United States | Research Site | DeSoto | Texas |
| United States | Research Site | Detroit | Michigan |
| United States | Research Site | Doral | Florida |
| United States | Research Site | East Providence | Rhode Island |
| United States | Research Site | El Paso | Texas |
| United States | Research Site | Evanston | Illinois |
| United States | Research Site | Flushing | New York |
| United States | Research Site | Fort Myers | Florida |
| United States | Research Site | Fort Wayne | Indiana |
| United States | Research Site | Fort Worth | Texas |
| United States | Research Site #1 | Fountain Valley | California |
| United States | Research Site #2 | Fountain Valley | California |
| United States | Research Site | Glendale | California |
| United States | Research Site | Glendale | Arizona |
| United States | Research Site | Gonzales | Texas |
| United States | Research Site | Granada Hills | California |
| United States | Research Site | Greenbelt | Maryland |
| United States | Research Site | Greenville | Texas |
| United States | Research Site | Greenville | Texas |
| United States | Research Site #1 | Greenville | North Carolina |
| United States | Research Site #2 | Greenville | North Carolina |
| United States | Research Site | Gulfport | Mississippi |
| United States | Research Site | Hampton | Virginia |
| United States | Research Site | Hialeah | Florida |
| United States | Research Site | Hialeah | Florida |
| United States | Research Site #1 | Hialeah | Florida |
| United States | Research Site #2 | Hialeah | Florida |
| United States | Research Site #3 | Hialeah | Florida |
| United States | Research Site #1 | Hollywood | Florida |
| United States | Research Site #2 | Hollywood | Florida |
| United States | Research Site | Houston | Texas |
| United States | Research Site | Houston | Texas |
| United States | Research Site #1 | Houston | Texas |
| United States | Research Site #2 | Houston | Texas |
| United States | Research Site | Huntsville | Alabama |
| United States | Research Site | Jacksonville | Florida |
| United States | Research Site #1 | Jacksonville | Florida |
| United States | Research Site #2 | Jacksonville | Florida |
| United States | Research Site | Jeffersonville | Indiana |
| United States | Research Site | Kansas City | Missouri |
| United States | Research Site | Kinston | North Carolina |
| United States | Research Site | Knoxville | Tennessee |
| United States | Research Site | La Mesa | California |
| United States | Research Site | Laguna Hills | California |
| United States | Research Site | Lake Worth | Florida |
| United States | Research Site | Lansdowne Town Center | Virginia |
| United States | Research Site #1 | Las Vegas | Nevada |
| United States | Research Site #2 | Las Vegas | Nevada |
| United States | Research Site | Lauderdale Lakes | Florida |
| United States | Research Site | Laurelton | New York |
| United States | Research Site #1 | Lawrenceville | Georgia |
| United States | Research Site #2 | Lawrenceville | Georgia |
| United States | Research Site | Lewisville | Texas |
| United States | Research Site | Lincoln | Nebraska |
| United States | Research Site | Long Beach | California |
| United States | Research Site | Long Beach | California |
| United States | Research Site | Los Angeles | California |
| United States | Research Site | Lynwood | California |
| United States | Research Site | Macon | Georgia |
| United States | Research Site | Madison | Wisconsin |
| United States | Research Site | Marion | Ohio |
| United States | Research Site | Maumee | Ohio |
| United States | Research Site #1 | McAllen | Texas |
| United States | Research Site #2 | McAllen | Texas |
| United States | Research Site | McHenry | Illinois |
| United States | Research Site | McKinney | Texas |
| United States | Research Site | McKinney | Texas |
| United States | Research Site | Memphis | Tennessee |
| United States | Research Site | Meridian | Idaho |
| United States | Research Site #1 | Merrillville | Indiana |
| United States | Research Site #2 | Merrillville | Indiana |
| United States | Research Site | Mesa | Arizona |
| United States | Research Site | Methuen | Massachusetts |
| United States | Research Site | Miami | Florida |
| United States | Research Site | Miami | Florida |
| United States | Research Site | Miami | Florida |
| United States | Research Site | Miami | Florida |
| United States | Research Site | Miami | Florida |
| United States | Research Site | Miami | Florida |
| United States | Research Site | Miami | Florida |
| United States | Research Site | Miami | Florida |
| United States | Research Site | Miami | Florida |
| United States | Research Site | Miami | Florida |
| United States | Research Site | Miami | Florida |
| United States | Research Site | Miami | Florida |
| United States | Research Site #1 | Miami | Florida |
| United States | Research Site #1 | Miami | Florida |
| United States | Research Site #2 | Miami | Florida |
| United States | Research Site #2 | Miami | Florida |
| United States | Research Site | Miami Beach | Florida |
| United States | Research Site | Miami Lakes | Florida |
| United States | Research Site | Miami Lakes | Florida |
| United States | Research Site | Miami Springs | Florida |
| United States | Research Site | Michigan City | Indiana |
| United States | Research Site | Monroe | Louisiana |
| United States | Research Site | Morehead City | North Carolina |
| United States | Research Site | Nashville | Tennessee |
| United States | Research Site | New Bern | North Carolina |
| United States | Research Site | New Haven | Connecticut |
| United States | Research Site | New Orleans | Louisiana |
| United States | Research Site | New York | New York |
| United States | Research Site | Newport News | Virginia |
| United States | Research Site | Norfolk | Virginia |
| United States | Research Site | Northridge | California |
| United States | Research Site #2 | Northridge | California |
| United States | Research Site | Omaha | Nebraska |
| United States | Research Site | Orangeburg | South Carolina |
| United States | Research Site | Pembroke Pines | Florida |
| United States | Research Site | Peoria | Illinois |
| United States | Research Site | Philadelphia | Pennsylvania |
| United States | Research Site | Phoenix | Arizona |
| United States | Research Site | Plano | Texas |
| United States | Research Site | Plymouth | Massachusetts |
| United States | Research Site | Pompano Beach | Florida |
| United States | Research Site | Pontiac | Michigan |
| United States | Research Site | Portland | Maine |
| United States | Research Site | Portland | Oregon |
| United States | Research Site | Portsmouth | New Hampshire |
| United States | Research Site | Riverside | California |
| United States | Research Site | Roseville | California |
| United States | Research Site | Roseville | Michigan |
| United States | Research Site | Sacramento | California |
| United States | Research Site | Saint Louis | Missouri |
| United States | Research Site | Saint Paul | Minnesota |
| United States | Research Site | Salem | Virginia |
| United States | Research Site | Salinas | California |
| United States | Research Site | Salt Lake City | Utah |
| United States | Research Site | San Antonio | Texas |
| United States | Research Site | San Antonio | Texas |
| United States | Research Site | San Antonio | Texas |
| United States | Research Site | San Antonio | Texas |
| United States | Research Site | San Antonio | Texas |
| United States | Research Site | San Diego | California |
| United States | Research Site #1 | San Dimas | California |
| United States | Research Site #2 | San Dimas | California |
| United States | Research Site | Santa Ana | California |
| United States | Research Site | Santa Fe | New Mexico |
| United States | Research Site | Santa Monica | California |
| United States | Research Site | Sherman | Texas |
| United States | Research Site | Sherman Oaks | California |
| United States | Research Site | Shreveport | Louisiana |
| United States | Research Site #1 | Shreveport | Louisiana |
| United States | Research Site | Stamford | Connecticut |
| United States | Research Site | Sweetwater | Florida |
| United States | Research Site | Tacoma | Washington |
| United States | Research Site | Takoma Park | Maryland |
| United States | Research Site | Tampa | Florida |
| United States | Research Site | Tampa | Florida |
| United States | Research Site | Tampa | Florida |
| United States | Research Site | Thousand Oaks | California |
| United States | Research Site | Tucson | Arizona |
| United States | Research Site | Tucson | Arizona |
| United States | Research Site | Tuscumbia | Alabama |
| United States | Research Site | Upland | California |
| United States | Research Site | Victoria | Texas |
| United States | Research Site | Voorhees | New Jersey |
| United States | Research Site | Waterbury | Connecticut |
| United States | Research Site | Wenatchee | Washington |
| United States | Research Site | West Columbia | South Carolina |
| United States | Research Site | Westminster | Colorado |
| United States | Research Site #1 | Whittier | California |
| United States | Research Site #2 | Whittier | California |
| United States | Research Site | Winston-Salem | North Carolina |
| United States | Research Site | Woodbridge | Virginia |
| Lead Sponsor | Collaborator |
|---|---|
| Akebia Therapeutics |
United States, Argentina, Australia, Brazil, Bulgaria, France, Hungary, Israel, Italy, Korea, Republic of, Malaysia, Mexico, New Zealand, Poland, Puerto Rico, Russian Federation, South Africa, Spain, Ukraine, United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Exploratory - Proportion of Participants With Hb Values Within the Target Range During the Primary Evaluation Period (Weeks 24 to 36) | Weeks 24 to 36 | ||
| Other | Exploratory - Proportion of Time With Hb Values Within the Target Range During the Primary Evaluation Period (Weeks 24 to 36) | Weeks 24 to 36 | ||
| Other | Exploratory - Proportion of Time With Hb Values Within the Target Range During the Secondary Evaluation Period (Weeks 40 to 52) | Weeks 40 to 52 | ||
| Other | Exploratory - Proportion of Participants With Hb Values Within the Target Range During the Secondary Evaluation Period (Weeks 40 to 52) | Weeks 40 to 52 | ||
| Other | Exploratory - Proportion of Participants With an Hb Increase of >1.0 g/dL From Baseline Visit | Baseline; up to Week 52 | ||
| Other | Exploratory - Time to Achieve Hb Increase of >1.0 g/dL From Baseline Visit | Baseline; up to Week 52 | ||
| Other | Exploratory - Mean Change in Hb Between Baseline (Mean Pretreatment Hb) and the Primary Evaluation Period (Mean Hb From Weeks 24 to 36) Stratified by Pre-baseline Erythropoiesis-stimulating Agent (ESA) Exposure | Baseline; Weeks 24 to 36 | ||
| Other | Exploratory - Mean Monthly Dose of Intravenous (IV) Elemental Iron Administered in Participants Who Have Received IV Iron | Up to Week 52 | ||
| Other | Exploratory - Proportion of Participants Receiving IV Iron Therapy | Up to Week 52 | ||
| Other | Exploratory - Proportion of Participants Receiving Red Blood Cells (RBCs) Transfusion(s) | Up to Week 52 | ||
| Primary | Change From Baseline in Hemoglobin (Hb) to the Average Over the Primary Efficacy Period (Weeks 24 to 36) | The Baseline average was calculated as the average of the Hb values obtained at the screening visit closest to the date of randomization and the randomization visit. The average for the Primary Efficacy Period was calculated as the average Hb value over Weeks 24 to 36. Analysis was conducted using an analysis of covariance (ANCOVA) model with multiple imputation for missing data with Baseline Hb concentration (<9.5 versus =9.5 grams per deciliter [g/dL]), geographic region (United States [US] versus European Union [EU] versus Rest of World [ROW]), and New York Heart Association congestive heart failure (NYHA CHF) class (Class 0 [no CHF] or I versus II or III) as covariates. | Baseline; Weeks 24 to 36 | |
| Primary | Median Time to First Major Adverse Cardiovascular Event (MACE) | MACE was defined as all-cause mortality, non-fatal myocardial infarction (MI), or non-fatal stroke. The primary safety outcome was positively adjudicated first MACE, which was defined as any death, Endpoint Adjudication Committee (EAC)-confirmed non-fatal MI, or EAC-confirmed non-fatal stroke occurring between the first dose date and each participant's last participation date. PROTECT MACE results and analysis, by design, was performed on pooled data from studies AKB-6548-CI-0014 (NCT02648347) and AKB-6548-CI-0015 (NCT02680574). Results and statistical analysis from study AKB-6548-CI-0014 has been reported in below table and under section "Statistical Analysis 1". Results and statistical analysis of the pooled data from studies AKB-6548-CI-0014 and AKB-6548-CI-0015 has been reported under section "Statistical Analysis 2" of this outcome measure. | Up to Week 208 | |
| Secondary | Change From Baseline in Hb to the Average Over the Secondary Efficacy Period (Weeks 40 to 52) | The Baseline average was calculated as the average of the Hb values obtained at the screening visit closest to the date of randomization and the randomization visit. The average for the Secondary Efficacy Period was calculated as the average Hb value over Weeks 40 to 52. Analysis was conducted using an ANCOVA model with multiple imputation for missing data with Baseline Hb concentration (<9.5 versus =9.5 g/dL), geographic region (US versus EU versus ROW), and NYHA CHF class (Class 0 [no CHF] or I versus II or III) as covariates. | Baseline; Weeks 40 to 52 | |
| Secondary | Median Time to First MACE Plus Hospitalization for Heart Failure or Thromboembolic Event Excluding Vascular Access Thrombosis | MACE was defined as all-cause mortality, non-fatal MI, or non-fatal stroke. Hospitalization for EAC adjudicated heart failure included presentation of participants to an acute care facility requiring an overnight hospitalization (change in calendar day) with an exacerbation of heart failure requiring treatment. EAC confirmed thromboembolic events for this secondary outcome measure included arterial thrombosis, deep vein thrombosis, and pulmonary embolism. PROTECT MACE results and analysis, by design, was performed on pooled data from studies AKB-6548-CI-0014 (NCT02648347) and AKB-6548-CI-0015 (NCT02680574). Results and statistical analysis from study AKB-6548-CI-0014 has been reported in below table and under section "Statistical Analysis 1". Results and statistical analysis of the pooled data from studies AKB-6548-CI-0014 and AKB-6548-CI-0015 has been reported under section "Statistical Analysis 2" of this outcome measure. | Up to Week 208 | |
| Secondary | Median Time to First Cardiovascular MACE | MACE was defined as all-cause mortality, non-fatal MI, or non-fatal stroke. Cardiovascular MACE analysis differed from the primary MACE endpoint as it included only deaths adjudicated by the EAC as cardiovascular deaths (i.e, only EAC-confirmed cardiovascular deaths) in addition to first events of non-fatal MI or non-fatal stroke. PROTECT MACE results and analysis, by design, was performed on pooled data from studies AKB-6548-CI-0014 (NCT02648347) and AKB-6548-CI-0015 (NCT02680574). Results and statistical analysis from study AKB-6548-CI-0014 has been reported in below table and under section "Statistical Analysis 1". Results and statistical analysis of the pooled data from studies AKB-6548-CI-0014 and AKB-6548-CI-0015 has been reported under section "Statistical Analysis 2" of this outcome measure. | Up to Week 208 | |
| Secondary | Median Time to First Cardiovascular Death | Cardiovascular death included EAC adjudicated fatal MI, pump failure, sudden death, presumed sudden death, fatal stroke, fatal pulmonary embolism, cardiovascular procedure-related death, other cardiovascular death, and presumed cardiovascular death. PROTECT MACE results and analysis, by design, was performed on pooled data from studies AKB-6548-CI-0014 (NCT02648347) and AKB-6548-CI-0015 (NCT02680574). Results and statistical analysis from study AKB-6548-CI-0014 has been reported in below table and under section "Statistical Analysis 1". Results and statistical analysis of the pooled data from studies AKB-6548-CI-0014 and AKB-6548-CI-0015 has been reported under section "Statistical Analysis 2" of this outcome measure. | Up to Week 208 | |
| Secondary | Median Time to First All-cause Mortality | Only events that were positively adjudicated and confirmed by the EAC were included in the MACE analyses. PROTECT MACE results and analysis, by design, was performed on pooled data from studies AKB-6548-CI-0014 (NCT02648347) and AKB-6548-CI-0015 (NCT02680574). Results and statistical analysis from study AKB-6548-CI-0014 has been reported in below table and under section "Statistical Analysis 1". Results and statistical analysis of the pooled data from studies AKB-6548-CI-0014 and AKB-6548-CI-0015 has been reported under section "Statistical Analysis 2" of this outcome measure. | Up to Week 208 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
| Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
| Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
| Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
| Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
| Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
| Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
| Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
| Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
| Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
| Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
| Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
| Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
| Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
| Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
| Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
| Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
| Terminated |
NCT01535781 -
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
|
N/A | |
| Completed |
NCT01432717 -
Study of ACE-536 in Healthy Postmenopausal Women
|
Phase 1 |